SELLAS Life Sciences (SLS) Divestments (2015 - 2016)
SELLAS Life Sciences (SLS) reported Divestments of -$1.0 million for Q1 2016, down 110.0% year-over-year from $10.5 million in Q2 2015, and down 109.31% on a QoQ basis from $11.3 million in Q4 2015.
SELLAS Life Sciences (SLS) has 2 years of Divestments data on file, last reported at -$1.0 million in Q1 2016.
- Quarterly Divestments fell 110.0% year-over-year to -$1.0 million in Q1 2016, while the trailing twelve-month figure through Dec 2016 was -$1.0 million (down 109.77% YoY) and the FY2016 annual result came in at -$1.0 million, down 109.77% from the prior year.
- Divestments declined to -$1.0 million in Q1 2016 per SLS's latest filing, from $11.3 million in the prior quarter.
- Across five years, Divestments topped out at $11.3 million in Q4 2015 and bottomed at -$1.0 million in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -1.05 Mn |
| Dec 31, 2015 | 11.28 Mn |
| Jun 30, 2015 | -34,000.00 |
| Mar 31, 2015 | -500,000.00 |